Exchange: NASDAQ·Updated 07:55 PM EDT
ACHV logo

ACHV Achieve Life Sciences Inc.

$8.49
$0.18
(2.17%)
Today
Closed $8.49
$0.22
(2.59%)
After Hours
Reported EarningsAug 11
Mkt Cap$873.64M
Vol886,366.00

About ACHV

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
36

Bearish Sentiment

How do you feel about ACHV?

Advertisement|Remove ads.